Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal gelified ethanol versus intradiscal steroid in lumbar discogenic pain
NCT03415828Recruiting
- Sponsor
- Gelscom
- Start
- May 2018
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Gelscom. Primary endpoint: Short-term efficacy profile at 3 months. Started May 2018; status: recruiting.
Beyond the preview
Go deeper on NCT03415828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415828.